Professional Documents
Culture Documents
2005 Jacc 36th Bethesda Conference Table of Contents
2005 Jacc 36th Bethesda Conference Table of Contents
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://content.onlinejacc.org
Table of Contents
Preamble .................................................................................1317
Introduction: Eligibility Recommendations for
Competitive Athletes With Cardiovascular Abnormalities
General Considerations.........................................................1318
Impetus for the Revision ...................................................1318
Definitions .........................................................................1318
Prevalence...........................................................................1318
Conference Design and Format ........................................1319
Recommendations for Disqualification and Eligibility .....1319
Special Considerations .......................................................1320
References ..........................................................................1321
Appendix 1.........................................................................1321
Task Force 1: Preparticipation Screening and Diagnosis
of Cardiovascular Disease in Athletes .................................1322
Preparticipation Screening .................................................1322
Diagnostic Testing Strategies ............................................1323
Athletes Heart and Cardiovascular Disease .....................1324
References ..........................................................................1325
Appendix 1.........................................................................1326
Task Force 2: Congenital Heart Disease ............................1326
General Considerations .....................................................1326
Types of Congenital Defects .............................................1326
References ..........................................................................1333
Appendix 1.........................................................................1333
Task Force 3: Valvular Heart Disease.................................1334
General Considerations .....................................................1334
Mitral Stenosis ...................................................................1334
Mitral Regurgitation ..........................................................1335
Aortic Stenosis ...................................................................1336
Aortic Regurgitation ..........................................................1337
Bicuspid Aortic Valves With Aortic Root Dilatation .........1338
Tricuspid Regurgitation.....................................................1338
Tricuspid Stenosis..............................................................1338
Multivalvular Disease.........................................................1338
Prosthetic Heart Valves .....................................................1338
Valve Repair or Percutaneous Mitral Balloon
Valvotomy .....................................................................1339
References ..........................................................................1339
Appendix 1.........................................................................1340
Task Force 4: HCM and Other Cardiomyopathies, Mitral
Valve Prolapse, Myocarditis, and Marfan Syndrome.........1340
Hypertrophic Cardiomyopathy ..........................................1340
Mitral Valve Prolapse (MVP) ...........................................1341
Myocarditis ........................................................................1342
Marfan Syndrome ..............................................................1342
Ehlers-Danlos Syndrome...................................................1343
Arrhythmogenic Right Ventricular Cardiomyopathy
(ARVC) ........................................................................1343
Other Myocardial Diseases................................................1343
Pericarditis..........................................................................1344
References ..........................................................................1344
Appendix 1.........................................................................1345
Table of contents
J. Am. Coll. Cardiol. 2005;45;1316
doi:10.1016/j.jacc.2005.02.003
This information is current as of March 5, 2010
Rights & Permissions
Reprints